Cancer Archives - Page 2 of 14 - Medicine Innovates

Propensity Score Matching Reveals Non-Significance of Male Sex as a Prognostic Factor in Differentiated Thyroid Cancer Post Iodine Treatment

4 weeks ago Cancer Comments Off on Propensity Score Matching Reveals Non-Significance of Male Sex as a Prognostic Factor in Differentiated Thyroid Cancer Post Iodine Treatment

Unsupervised Machine Learning Helps Discover Patterns of Racial Disparities in Breast Cancer Patients

February 18, 2025 Cancer, Translational Medicine Comments Off on Unsupervised Machine Learning Helps Discover Patterns of Racial Disparities in Breast Cancer Patients

Enhanced Diagnostic Accuracy of Tc-PSMA SPECT/CT vs. mpMRI in Prostate Cancer Staging and Relapse Detection

February 1, 2025 Cancer Comments Off on Enhanced Diagnostic Accuracy of Tc-PSMA SPECT/CT vs. mpMRI in Prostate Cancer Staging and Relapse Detection

Breaking Ground in CLL Research: Novel Mouse Model Unveils New Therapeutic Pathways

January 15, 2025 Cancer Comments Off on Breaking Ground in CLL Research: Novel Mouse Model Unveils New Therapeutic Pathways

PC4 Mediated Enhancement of NHEJ Repair Promotes Radioresistance in Hepatocellular Carcinoma

December 12, 2024 Cancer Comments Off on PC4 Mediated Enhancement of NHEJ Repair Promotes Radioresistance in Hepatocellular Carcinoma

SRSF1: Key Player in Pancreatic Ductal Adenocarcinoma Initiation and Progression

November 28, 2024 Cancer Comments Off on SRSF1: Key Player in Pancreatic Ductal Adenocarcinoma Initiation and Progression

Durvalumab and Ceralasertib Blaze a New Trail in NSCLC Therapy

November 26, 2024 Cancer, Precision Medicine Comments Off on Durvalumab and Ceralasertib Blaze a New Trail in NSCLC Therapy

Metabolic Reprogramming of Tumor-Associated Macrophages via the GM-CSF–PPARγ Axis Supports EGFR-Mutant Lung Adenocarcinoma Progression: Therapeutic Implications

November 25, 2024 Cancer Comments Off on Metabolic Reprogramming of Tumor-Associated Macrophages via the GM-CSF–PPARγ Axis Supports EGFR-Mutant Lung Adenocarcinoma Progression: Therapeutic Implications